Based on the primary sample HCC data, subgroup-2 lines should exhibit high expression and low methylation of both TIAM1 and LDHB, while non-HCC-subgroup-2 lines would exhibit low expression and high methylation for both genes. The gene discussed is LDHB; the disease is hepatocellular carcinoma.